Business
Coronavirus vaccine: Oxford, AstraZeneca resume trial after patient’s serious side-effect – PerthNow
Days after a vaccine trial was suspended following a reported side-effect in a UK patient, Oxford University has announced the study will resume.
Oxford University has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.
In a statement on Saturday, the university confirmed the restart across all of its UK clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The independent review process has concluded and following the recommendations of…
-
Business21 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News22 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News23 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News16 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track